Glutathione transferase deficient mice to probe for adverse drug reactions [ 2007 - 2009 ]

Research Grant

Researchers: Prof Philip Board (Principal investigator) ,  A/Pr Anneke Blackburn ,  Alison Shield ,  Prof Jane Dahlstrom ,  Prof Klaus Matthaei
View all 6 related researchers

Brief description A family of enzymes called glutathione transferases (GST) that metabolize foreign chemicals and therapeutic drugs have been shown to be a significant cause of drug resistance in cancer chemotherapy. It has been suggested that inhibitors of GSTs could be used in cancer treatment to counter drug resistance or to slow the metabolism and enhance the activity of some drugs. Some GSTs carryout important enzymatic reactions with endogenous substrates and others have important non-enzymatic functions such as the regulation of signaling pathways within cells and the modulation of calcium ion channels that are involved in muscle contractions. The generic inhibition of all GSTs could therefore have significant adverse physiological effects. We propose to make mice deficient in specific GSTs and to study their physiological responses. The results of these studies will indicate which GSTs can be safely inhibited without the risk of deleterious side effects. These studies are important because adverse reactions to therapeutic drugs are a significant cause of hospital admissions and death.

Funding Amount $AUD 562,933.42

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant